Post-Notice of Compliance (NOC) Changes: Safety and Efficacy Document (English, HTML)

View metadata and access the original English HTML file: Post-Notice of Compliance (NOC) Changes: Safety and Efficacy Document.

Format

HTML

Access

file-only

Publisher-reported update

2021-07-07

This guidance document applies to sponsors intending to make changes to new drugs that have received a NOC pursuant to section C.08.004 of the Food and Drug Regulations. These new drugs may include pharmaceuticals, biologics, and radiopharmaceuticals for human use and pharmaceutical and certain biotechnological products for veterinary use, including those submissions for which a NOC has been recommended but issuance of the NOC has been placed on hold.

Access original file